New data published by the UK Health Security Agency (UKHSA) has revealed that London is potentially at risk of a measles resurgence.
UKHSA modelling suggests that, unless MMR vaccination rates improve, London could see a measles outbreak with tens of thousands of cases.“Those who have never received a measles vaccine (MMR) are at risk,” said UKHSA.MMR is part of the NHS Routine Childhood Immunisation Programme. Parents whose infants missed out, or anyone of any age unvaccinated, are urged to come forward.Susceptibility is particularly high among 19 to 25 year olds, affected by unfounded stories in the early 2000s (‘Wakefield cohorts’) and some may still not be fully vaccinated.As part of continued efforts to protect people against getting measles, the NHS is launching a campaign encouraging people to check their vaccination status, with targeted outreach to groups in London.Data published today by the UK Health Security Agency (UKHSA) shows there has been a steady rise in measles cases this year. It shows, between 1 January and 30 June this year there have been 128 cases of measles, compared to 54 cases in the whole of 2022, with 66 per cent of the cases detected in London although cases have been seen in all regions.The UKHSA assessment finds the risk of a measles epidemic across the UK is considered low. However, with lower current levels of coverage in London, a measles outbreak of between 40,000 and 160,000 cases could occur in the capital.The assessment also concludes that there is a high risk of cases linked to overseas travel leading to outbreaks in specific population groups such as young people and under-vaccinated communities.The risk in London is primarily due to low vaccination rates over several years, further impacted by the COVID-19 pandemic, particularly in some areas and groups where coverage of the first MMR dose at 2 years of age is as low as 69.5%.NHS England has launched a targeted national campaign to encourage uptake of the MMR vaccine, including targeted outreach work in London for those identified as at high risk and communities with the lowest uptake of vaccination.This Site is Intended for Healthcare Professionals Only
Search
AI Powered
Human content,
AI powered search.
Latest Stories
Start your day right!
Get the latest updates and insights delivered to your inbox
Related News
More For You
Call to improve inclusivity in clinical research
Jun 13, 2025
A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.
The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.
A 2024 Ipsos study found that while 58 per cent of UK adults were willing to participate in clinical trials, this dropped to 41 per cent among ethnic minority adults.
It found that during a clinical trial, only 36 per cent of ethnic minority adults participated, compared with 46 per cent of white adults.
The survey also highlighted gender disparities within ethnic minority groups.
Black, African, or Caribbean women were more likely to feel uncomfortable in healthcare environments than other ethnic minority groups.
The ABPI and AMRC held a joint event to understand the barriers that might prevent people from participating in clinical trials, and how to overcome them.
The event brought together representatives from across the UK clinical research sector, including the pharmaceutical industry, health charities, regulatory bodies, government, and the NHS.
The speakers called for a UK-wide strategy to drive greater diversity and inclusion in clinical trials and develop an approach for measuring, collecting, and reporting clinical trial diversity.
The practical barriers that prevent diverse populations from participating in clinical research include financial burden, such as travel costs, childcare expenses, and lost wages.
Since most clinical trial appointments are during weekdays, many find it difficult to take time off from work.
The solutions include providing financial support such as stipends, reimbursements, or other financial assistance to cover transportation, childcare, and lost wages.
Another suggestion was conducting trials in community health centres and mobile units to enable researchers to engage rural and underserved urban populations.
They also called for clear communication about logistics, remuneration, and support to encourage higher levels of participation, and offer translation services to accommodate non-native speakers.
Keep ReadingShow less
Most Popular
Don’t Miss Out
Get the latest updates and insights delivered to your inbox.
By subscribing, you agree to our Terms & Conditions.
View Terms & Conditions×
Terms and Conditions
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Asian Trade
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at
data@amg.biz
to see how we manage and store your data.
Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.
iStock
Pharmacy students to have access to Learning Support Fund
Jun 13, 2025
FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.
The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).
Unlike their peers in other healthcare degree programmes, such as nursing, midwifery, and medicine, pharmacy students were excluded from the entire LSF.
While many pharmacy schools provided some money towards these expenses, it was meagre when compared with TDAE funding.
The updated LSF guidance states that, from the 2025 to 2026 academic year, new and continuing undergraduate pharmacy students, as well as pre-registration healthcare science students, can access the TDAE provision.
Pharmacy students had in 2023 launched a Fair Funding Campaign, and many MPharm students wrote to the MPs, highlighting this disparity.
The new measure would be helpful for students hailing from lower-income households.
Students can now undertake placements in diverse healthcare settings without worrying about the cost of travel and accommodation.
The Royal Pharmaceutical Society (RPS) has welcomed the inclusion of pharmacy students in the LSF.
RPS president professor Claire Anderson sees this as “A welcome recognition by the Government of the crucial role of pharmacists in the future NHS."
“As pharmacists play a more clinical role in the health service, it seemed increasingly unjust to exclude pharmacy students from the financial support they deserve," she added.
Keep ReadingShow less
Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.
Pic credit: iStock
NHS pushes for robotic surgery to reduce waiting time, improve outcomes
Jun 12, 2025
The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.
As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.
NHS officials claim that by 2035 9 in 10 of all keyhole surgeries, such as the removal of certain organs affected by cancer, will be delivered with robot assistance, up from 1 in 5 today.
Robotic surgery allows greater dexterity than traditional keyhole surgeries, and it is easier to manipulate as the instruments are controlled by a surgeon at a console using a 3D camera.
The NHS also expects to see increasing numbers of emergency operations using the space-age tech – which can be more precise than the human hand.
Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.
In some cases the hospital stay is cut by nearly half when compared with those undergoing traditional surgery.
The new NHS England forecast follows the publication of its first ever national guidance on robotic programmes.
In recent years, the range of operations involving robots has widened – in 2011/12 urological cancer surgery made up 80 per cent.
But by 2023/24 its proportion dropped to 44 per cent even though the number of operations had increased.
There has been a significant growth in areas such as colorectal, gynaecology, ear, nose and throat, and orthopaedic procedures.
Health and social care secretary Wes Streeting, a cancer survivor, said: “Innovative treatments and technologies that help fast track better outcomes for patients is how we transform our NHS and make it fit for the future.
"I know myself how important this is, when the NHS saved my life from kidney cancer with an operation led by a world-class surgeon being helped by a robot."
Sir Jim Mackey, NHS Chief Executive, said, “The NHS has pledged to return to shorter elective waiting times by 2029 and we are using every tool at our disposal to ensure patients get the best possible treatment."
John McGrath, chair of the NHS England Steering Committee for Robotic Assisted Surgery, said, “Faster recovery and shorter hospital stays are not only hugely important benefits for patients undergoing surgery, if used efficiently they can have a positive impact on the rest of the system by relieving pressure on services and therefore helping to reduce waiting times."
Keep ReadingShow less
The amendment ensures that every person who receives health care or a social service in Scotland will have a digital care record
Pic credit: iStock
Scotland's move to create digital patient care record hailed
Jun 12, 2025
The Royal Pharmaceutical Society (RPS) in Scotland has welcomed the decision of the Scottish Parliament to create an integrated digital patient care record.
The move came during a debate on the Care Reform (Scotland) Bill on Tuesday (10), when Jackie Baillie tabled an amendment to ensure that every person who receives health care or a social service in Scotland has a digital care record.
The amendment said this record must be enabled for "secure and efficient sharing of data between health care and social services so that people’s experiences are as safe and seamless as possible.
"It would also allow people to access their own health and care information, in a format accessible to them."
Another member Brian Whittle also tabled an amendment to ensure that this record can be integrated between different systems.
Both amendments were voted through as part of the Care Reform (Scotland) Bill.
RPS said it had made this objective a key point of its vision for pharmacy’s future, and has consistently raised the demand among the MSPs.
The society said this legislation creates the conditions for community pharmacies to have access to patient records, and it will work with the government to ensure that this becomes a reality.
RPS director for Scotland Laura Wilson welcomed the legislation and said it will help improve patient care, experience and safety.
"This will become even more important in 2026 when all pharmacists qualify as prescribers."
Brian Whittle, who brought one the amendments, expressed happiness regarding the passage of amendment and thanked RPS for support.
He said this will ensure patient safety and improve the working conditions of healthcare professionals.
Keep ReadingShow less
Cambridge University academics have flagged concerns over the safety of period tracker apps
Pic credit: iStock
Users of period tracking apps face privacy, safety risk, say experts
Jun 12, 2025
The report said the apps provide a "gold mine" of data for consumer profiling and warn that in the wrong hands it could pose a safety risk
CAMBRIDGE UNIVERSITY academics have flagged concerns over the safety of period tracker apps and warned that the women using them could face privacy and safety risks.
A report by the university's Minderoo Centre for Technology and Democracy, an independent team of researchers, have stated that the personal information collected in these apps - including exercise, diet, medication, sexual preferences, hormone levels and contraception use - could be "sold at scale".
The report said the apps provide a "gold mine" for consumer profiling and collecting information, and academics warn that in the wrong hands, the data could result in health insurance "discrimination" and risks to job prospects.
The researchers pointed out that many women download the apps when they are trying to get pregnant, which alters their shopping behaviour.
"Data on who is pregnant, and who wants to be, has therefore emerged as some of the most sought-after information in digital advertising," they said.
The report stated that companies operating cycle tracking apps (CTA) get access to "extremely valuable and fine-grained user data".
The experts warned that this data is not only commercially valuable and shared with third parties, they also pose security risks for users.
They called for improving data security and "meaningful consent options" in these apps and urged public health bodies like the NHS to launch alternatives.
Keep ReadingShow less
Load More
© Copyright 2025 Garavi Gujarat Publications Ltd & Garavi Gujarat Publications USA Inc